Diagonal Bio AB (publ) (NGM:DIABIO)
Sweden · Delayed Price · Currency is SEK 0.0080
-0.0010 (-11.11%)
At close: Sep 15, 2025
Diagonal Bio AB Market Cap
Diagonal Bio AB has a market cap or net worth of 13.11 million as of September 16, 2025. Its market cap has increased by 31.99% in one year.
Market Cap
13.11M
Enterprise Value
10.38M
Revenue
1.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.01
Market Cap Chart
Since July 16, 2021, Diagonal Bio AB's market cap has decreased from 139.06M to 13.11M, a decrease of -90.57%. That is a compound annual growth rate of -43.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 13.11M | 97.16% |
| Dec 30, 2024 | 6.65M | -52.86% |
| Dec 29, 2023 | 14.11M | 40.22% |
| Dec 30, 2022 | 10.06M | -87.72% |
| Dec 30, 2021 | 81.97M | -41.05% |
| Jul 16, 2021 | 139.06M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 94.86B |
| Sectra AB | 60.54B |
| Getinge AB | 57.72B |
| Camurus AB | 40.94B |
| Medicover AB | 39.41B |
| Asker Healthcare Group AB | 36.24B |
| BioArctic AB | 23.97B |
| AddLife AB | 22.86B |